Endometriosos (EMS) is one of the common diseases in women of reproductive age, and its incidence has increased significantly in recent years, ranging from 3% to 10%, with a significant upward trend, so it is receiving more and more attention. Endometriosis refers to the ectopic endometrial tissue with growth function outside the uterine cavity, and can be divided into peritoneal endometriosis, ovarian endometriosis and uterine adenomyosis, which are mostly seen in women aged 20-40 years, and the incidence is increasing year by year, and is now considered to account for about 10% of women in their reproductive years. The clinical manifestations of the disease are diverse, with dysmenorrhea, painful intercourse, pelvic pain, menstrual irregularities and infertility as the main manifestations, and up to 60% to 80% of women with pelvic pain and infertility. For the pathogenesis of EMS, Professor Lang Jinghe proposed the “in situ endothelial determinism” of EMS, that is, whether endothelial fragments in menstrual blood of different individuals (patients and non-patients) can adhere, invade and grow in “foreign places”, the in situ endothelium is the key and is the determinant of EMS. This theory is an important finding in recent studies on the etiology of EMS, and in particular, it is an important addition and development to the Sampson’s theory. In conclusion, the pathogenesis of EMS is still unclear, from the earliest proposal of the epithelial chemotaxis of the corpora cavernosa to the later proposals of hormonal, environmental, immune and genetic theories, there are many theories of the pathogenesis of EMS, which are not single and independent but interrelated and complementary. In terms of diagnosis, in the last decade or two since the prevalence of laparoscopic techniques, the diagnosis of endoheteropathy has been based on laparoscopy as the “gold standard” for diagnosis, which allows a more comprehensive view of the lesion, staging according to the American Fertility Society (AFS) 1985 revised endoheteropathy staging method (r-AFS), and obtaining tissue biopsy. Currently, the main treatments for endometriosis (EMS) at home and abroad include hormone therapy, surgery, and Chinese medicine. The “current policy” of pain management, surgery, medication or surgery combined with medication has defects, namely: (1) usually short course of treatment or short time; (2) medication side effects, which become obvious with the prolongation of medication; (3) easy recurrence after treatment, and more and faster recurrence with conservative surgery; (4) expensive medication due to and long and repeated treatment, the treatment cost is large; (5) lack of evidence-based medicine based on large samples of randomized controlled trials. Although there are many endometriosis therapies, there is a lack of perfect methods to achieve relief of patient’s pain and recovery of pregnancy. Especially for patients with moderate or severe endometriosis, the lesions are large and extensive, with severe fibrosis and uterine and adnexal adhesions, and drug therapy alone is often ineffective, so surgery is still a major tool. Laparoscopic surgery can serve to remove endometriotic lesions and achieve the purpose of corresponding treatment while diagnosing the disease, avoiding the patient’s trouble of taking drugs for a long time after surgery, and the main reason for starting to choose surgical treatment is obviously better compared with drug treatment. Leng Jinhua, Lang Jinghe, etc. believe that: if endoheterosis appears as pelvic mass, infertility or pelvic pain, those who are ineffective by medication should consider surgery, surgery includes conservative surgery and radical surgery, domestic and foreign experience has proved that laparoscopic surgery is less traumatic than open surgery, patients recover quickly, abdominal scar is small, postoperative adhesions are light, all endoheterosis within each period are suitable for laparoscopic surgery, therefore, laparoscopic surgery has almost no Therefore, there are almost no contraindications to laparoscopic surgery, and laparoscopic surgery is the preferred method for the treatment of endometriosis, and at present, conservative surgery is usually done through laparoscopy. Currently, the treatment of endo is still a very difficult problem, one of the reasons being the recurrence problem, which exists regardless of the treatment. The rate of recurrence of endo is highly variable depending on the diagnostic criteria and population, the diagnostic criteria for recurrence, the surgical approach, the ethnicity of the person and the length of follow-up. According to several clinical studies, the recurrence rate is higher with drug therapy alone, comparable with laparoscopic surgery and open surgery, and lowest with combined surgical/drug therapy. The recurrence rate after surgery is generally agreed to be lower than that of drug therapy alone, and the recurrence rate after surgery is reported in the literature to be between 2% and 47%, with most studies showing a recurrence rate of 20%-40% 5 years after surgery for endometriosis and a recurrence rate seen at the time of reoperation ranging from 0.9% in the first year to 13.6% in the eighth year after surgery. The cumulative incidence of recurrence/persistence of conservative surgical treatment of endometriosis was 5.7%-7.1% at year 1 postoperatively, 11.7% at 4 years, 19% at 5 years, and 31.6% at year 7 postoperatively, with a mean recurrence time of 19.7 (5-60) months, respectively. The cumulative recurrence rate of laparoscopic surgery to remove ovarian endometrioma was 7.1% at one year after surgery, 3.3% at reoperation, and 11.7% at 48 months by ultrasound. Recurrence after laparoscopy: The German study showed that the overall recurrence rate within 5 years after surgery was 58.4%. The more advanced the stage of endoheterosis, the more active the lesion. Therefore, the 8th International Conference on Endometriosis emphasized the objectives of endometriosis treatment: (1) pain relief and control; (2) treatment and promotion of fertility; (3) reduction and removal of lesions; (4) prevention and reduction of recurrence. Biological basis of EMS recurrence: Experiments showed that ectopic foci were produced in mice by surgical induction, and regression of endometriotic lesions was seen after 42 d of treatment with Gn-RHa, but the lesions returned naturally 3 weeks after discontinuation of the drug or within 3 d after hormone replacement therapy. Also lesion progression was paralleled by serum steroid hormone levels. In addition, the reappearance of lesions on top of the original lesions suggests that recurrent endometriosis is the result of regrowth of the original lesions rather than new lesions, thus suggesting two conclusions: (1) in ectopic implant foci, active endometrial cells are still present even though their morphology is atrophic and degenerative, and (2) ovarian steroid hormones are the main, but not the only, factor associated with the regrowth of ectopic endometrial implant foci. factors associated with regrowth. The main factors affecting recurrence: (1) age: studies have shown that the average age of EMS recurrence is smaller than that of non-recurrence, but it is not related to the age of menarche, for the reason that EMS is a hormone-dependent disease, as the patient ages, the ovarian function gradually declines, estrogen secretion decreases, and it can tend to heal spontaneously, thus the chance of recurrence is small; (2) postoperative r.AFS score: postoperative r.AFS score Domnez j believes that drug therapy cannot prevent recurrence, but can relieve pain and improve pregnancy rate. Shi Yifu believes that different types of drugs produce different treatment outcomes. Xiao Qing et al. study, on the other hand, showed that postoperative adjuvant therapy was not associated with recurrence. Li Huajun et al. found that 6 months of postoperative progestin therapy did reduce its recurrence, but the 3-month treatment group did not reduce the recurrence rate, suggesting that when EMS patients are treated with progestin after conservative surgery, the effect on recurrence should be considered when choosing the course of therapy. Nowadays, gonadotropin-releasing hormone agonist has become the drug of choice for EMS, and its effect on recurrence has been reported, but the results are still inconsistent; (4) ovarian chocolate cysts: Xiao Qing et al. showed that the diameter of ovarian chocolate cysts is not related to recurrence, which is consistent with Salch’s view. The reason for this is that the walls of large cysts are easily exposed and removed, but the walls of small, multi-room, thick-walled fibrosis-heavy chocolate cysts are easily left behind, which inevitably leaves more active lesions and more pathogenic factors, resulting in recurrence. (5) Laparoscopic surgery: laparoscopic surgery can remove or cauterize endometriosis foci seen by the naked eye. Because of its image magnification, the surgery is more effective than cesarean surgery in exploring and treating microscopic lesions, but its limitations are revealed when separating extensive adhesions. Therefore, for patients with endometriosis who do not have heavy adhesions, laparoscopy is recommended for the first surgery to ensure the thoroughness of the surgery to reduce the recurrence rate; (6) Other high-risk factors include: (1) EMS lesion side: some studies have concluded that more lesions occur in the left ovary than in the right, and they are also prone to recurrence after treatment, and the pregnancy rate is also lower, and bilateral ovarian lesions are also prone to recurrence; (2) painful nodules in the posterior fornix; they are mostly of the vaginorectal compartment type, or mostly combined with the vaginorectal compartment, and the lesions are deeply infiltrated, not easily removed completely, and also prone to recurrence; (3) postoperative clomiphene citrate treatment: the results of the study found that (3) postoperative clomiphene citrate treatment: the results of the study found that the application of clomiphene citrate for more than 2 courses of postoperative ovulation treatment can lead to recurrence of EMS, the reasons for which are not known. There is no record of endometriosis in ancient Chinese medical texts. However, there are similar descriptions in Chinese medical texts. It is found in Chinese medical treatises on “dysmenorrhea”, “obstruction in the abdomen”, “irregular menstruation” and “infertility”. For example, in the “Golden Horoscope”, “menstrual flow is unfavorable and the abdomen is full of pain”, “a woman is 50 years old. …… ever half-birth. Blood stasis in the small abdomen does not go.” The evaluation school liu selected four medical cases said: “painful menstruation for several years, can not conceive, menstrual water three days before must abdominal pain, abdominal block stagnation …… inquired of the boudoir when there is no disease, both married after there is.” Chinese medicine believes that the etiology of this disease is that the blood from the menstruation can not be discharged from the body. The stasis accumulates in the lower jiao, affecting the qi flow, forming obstruction over time, not pass is painful, serious dysmenorrhea occurs; two essence can not be combined, resulting in infertility. The cause of this disease has been recognized differently by doctors throughout the ages. But all of them are based on the theory of blood stasis. The Chinese standard of diagnosis and treatment for endometriosis has been recognized as blood stasis in the Chinese and Western medicine combined conference held in Xi’an in 1990. Modern TCM research results on EMS are summarized as follows: (1) the disease is mainly caused by internal obstruction of blood stasis, and the treatment is based on activating blood stasis as the main method; (2) on the basis of blood stasis, there are also qi stagnation, cold condensation, phlegm-dampness and kidney deficiency. (3) Therapeutic mechanism of Chinese medicine: Modern Chinese medicine research has studied from multiple perspectives, such as endocrine, cytokine and histological changes, and found that Chinese medicine has the effects of anti-inflammatory and analgesic, mediating endocrine function, improving blood rheology, regulating immune function, promoting apoptosis of ectopic endometrium and inhibiting blood vessel formation, which can effectively treat endometriosis. Based on this, Chinese medicine treatment for EMS has gradually been emphasized in recent years, and there are reports from home and abroad that Chinese medicine has been used to treat this disease with good clinical efficacy. The methods include preserved enema, acupuncture, oral Chinese medicine, etc. The literature shows that its advantages include no or minimal side effects, effective elimination of lesions and relief of syndromes, full integration of modern medical research progress, organic linkage between Chinese and Western medical theory and clinical application, combination of evidence and disease identification, flexible medication, etc.